These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 17972522)

  • 1. MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer.
    Quaranta M; Daniele A; Coviello M; Venneri MT; Abbate I; Caringella ME; Di Tardo S; Divella R; Trerotoli P; Di Gennaro M; Schittulli F; Fransvea E; Giannelli G
    Anticancer Res; 2007; 27(5B):3593-600. PubMed ID: 17972522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
    Sliwowska I; Kopczyński Z
    Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression.
    Kim SH; Cho NH; Kim K; Lee JS; Koo BS; Kim JH; Chang JH; Choi EC
    J Surg Oncol; 2006 Mar; 93(4):330-7. PubMed ID: 16496371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy.
    Chan LW; Moses MA; Goley E; Sproull M; Muanza T; Coleman CN; Figg WD; Albert PS; Ménard C; Camphausen K
    J Clin Oncol; 2004 Feb; 22(3):499-506. PubMed ID: 14752073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
    Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
    Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer.
    Sivula A; Talvensaari-Mattila A; Lundin J; Joensuu H; Haglund C; Ristimäki A; Turpeenniemi-Hujanen T
    Breast Cancer Res Treat; 2005 Feb; 89(3):215-20. PubMed ID: 15754118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum level of pro-matrix metalloproteinase 2 correlates with aggressive behavior in breast carcinoma.
    Kuvaja P; Talvensaari-Mattila A; Pääkkö P; Turpeenniemi-Hujanen T
    Hum Pathol; 2006 Oct; 37(10):1316-23. PubMed ID: 16949931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.
    Shah FD; Shukla SN; Shah PM; Shukla HK; Patel PS
    Indian J Cancer; 2009; 46(3):194-202. PubMed ID: 19574670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery.
    Sancak B; Coskun U; Gunel N; Onuk E; Cihan A; Karamercan A; Yildirim Y; Ozkan S
    Intern Med J; 2004 Jun; 34(6):310-5. PubMed ID: 15228391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
    Hao L; Zhang C; Qiu Y; Wang L; Luo Y; Jin M; Zhang Y; Guo TB; Matsushima K; Zhang Y
    Cancer Lett; 2007 Aug; 253(1):34-42. PubMed ID: 17306924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer.
    Daniele A; Zito AF; Giannelli G; Divella R; Asselti M; Mazzocca A; Paradiso A; Quaranta M
    Anticancer Res; 2010 Sep; 30(9):3521-7. PubMed ID: 20944132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy.
    Rahko E; Jukkola A; Melkko J; Paavo P; Bloigu R; Talvensaari-Mattila A; Turpeenniemi-Hujanen T
    Anticancer Res; 2004; 24(6):4247-53. PubMed ID: 15736480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours.
    Kolomecki K; Stepien H; Bartos M; Kuzdak K
    Endocr Regul; 2001 Mar; 35(1):9-16. PubMed ID: 11308991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clodronate treatment influences MMP-2 associated outcome in node positive breast cancer.
    Leppä S; Saarto T; Vehmanen L; Blomqvist C; Elomaa I
    Breast Cancer Res Treat; 2005 Mar; 90(2):117-25. PubMed ID: 15803358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients.
    Scorilas A; Karameris A; Arnogiannaki N; Ardavanis A; Bassilopoulos P; Trangas T; Talieri M
    Br J Cancer; 2001 Jun; 84(11):1488-96. PubMed ID: 11384099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical excision promotes tumor growth and metastasis by promoting expression of MMP-9 and VEGF in a breast cancer model.
    Zhao T; Xia WH; Zheng MQ; Lu CQ; Han X; Sun YJ
    Exp Oncol; 2008 Mar; 30(1):60-4. PubMed ID: 18438343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
    Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
    Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
    Liu R; Pu DM; Cheng YX; Yin L
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
    Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T
    J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.